[Management of oral anticoagulation during invasive procedures].
Temporary interruption of oral anticoagulation to perform invasive procedures is a frequently occurring medical problem. There are only a few studies available on the optimal clinical approach in this situation. The published clinical studies and guidelines are summarized.
Watzke
Herbert H
HH
Klinische Abteilung für Hämatologie und Hämostaseologie, Universitätsklinik für Innere Medizin I, Medizinische Universität Wien, Wien, Osterreich. herbert.watzke@meduniwien.ac.at
D000074:Acenocoumarol / Q000008:administration & dosage; D000925:Anticoagulants / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004724:Endoscopy; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage; D006801:Humans; D007231:Infant, Newborn; D013511:Minor Surgical Procedures; D017410:Practice Guidelines as Topic; D011655:Pulmonary Embolism / Q000517:prevention & control; D012307:Risk Factors; D055502:Secondary Prevention; D020246:Venous Thrombosis / Q000517:prevention & control*; D014812:Vitamin K / Q000037:antagonists & inhibitors; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014812:Vitamin K; D014859:Warfarin; D000074:Acenocoumarol